AMN Stock Analysis: Buy, Sell, or Hold?
AMN - AMN Healthcare Services
$18.73
-0.18 (-0.95%)
▼
5d:
+1.85%
30d:
-3.85%
90d:
+16.34%
BUY
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Distribution
AMN is up 3.6% this week, but smart money is buying puts. Top strike: $20 2026-05-15 with 13 OI. Put ratio: 93% View Scanner →
Strength: 6.1/10
Get Alerted When AMN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AMN shows positive signals but monitor for confirmation. Market pricing in 9.7% decline. Moderate conviction.
💡 BUY OPPORTUNITY: AMN shows positive signals but monitor for confirmation. Market pricing in 9.7% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.23
Based on -20.5% avg growth
INTRINSIC VALUE TODAY
$4.49
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AMN is currently trading at $18.73, which is considered slightly low relative to its 30-day fair value range of $18.31 to $20.80. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.9) compared to its historical average (22.9). Remarkably, the market is currently pricing in an annual earnings decline of 9.7% over the next few years. This pessimistic expectation contrasts with the company's recent 321.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, AMN is in a uptrend. Immediate support is located at $17.48, while resistance sits at $19.62.
Market Sentiment: AMN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $22.21 (+17.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AMN is in a uptrend. Immediate support is located at $17.48, while resistance sits at $19.62.
Market Sentiment: AMN has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $22.21 (+17.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$18.31 -
$20.80
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($22.21)
Fair Price Analysis
30-Day Fair Range
$18.31 -
$20.80
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$1.64
(8.8%)
Support & Resistance Levels
Support Level
$17.48
Resistance Level
$19.63
Current Trend
Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.87
Wall Street Target
$22.21
(+17.5%)
Revenue Growth (YoY)
1.8%
Earnings Growth (YoY)
321.3%
Profit Margin
-3.5%
Valuation Discount vs History
-9.7% cheaper
PE vs Historical
16.9 vs 22.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.7%
(market-implied from PE analysis)
1-Year Target
$17.08
(-10%)
2-Year Target
$15.42
(-19%)
3-Year Target
$13.92
(-26%)
3-Yr Target (if PE normalizes)
(PE: 17→23)
$18.90
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: -44.9%)
$18.30
(+-3%)
Base:
(SPY PE: 16.9, Growth: -44.9%)
$13.79
(-27%)
Bear:
(PE: 14.3, Growth: -44.9%)
$11.72
(-38%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.9 to 22.9
Stabilization Target:
$25.67
(+35.7%)
PE Expansion Potential:
+35.7%
Share & Embed Analysis
Last updated: March 30, 2026 4:30 PM ET
Data refreshes hourly during market hours. Next update: 5:30 PM
Data refreshes hourly during market hours. Next update: 5:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AMN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 62 BUY |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 64 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 48 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$140 | 54 HOLD |
Advanced AMN Option Strategies
Professional options setups generated by AI based on today's AMN price and gamma walls.
